Axogen
Axogen Inc is a medical technology company focused on the development and commercialization of proprietary surgical solutions for peripheral nerve repair and regeneration. The company provides a comprehensive portfolio of nerve repair products, including Avance Nerve Graft, Avive Soft Tissue Membrane, and AxoGuard Nerve Connector, utilized by surgeons in treating traumatic nerve injuries and chronic neuropathies. Its core operations encompass biomedical tissue processing, surgical device manufacturing, clinical research, and medical product distribution. Revenue is derived primarily from the direct sale of specialized nerve repair biological grafts and surgical accessories to hospitals and ambulatory surgery centers. Axogen holds a leading market position in surgical peripheral nerve reconstruction solutions. The company is headquartered in Alachua, Florida, United States, and its common stock trades on the Nasdaq Global Select Market.
6 of the funds FundTelligence covers report a position in Axogen.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 6
Funds holding Axogen
- Polar Capital Healthcare Opportunities Fund — Polar Capital · 3.3 % (largest positions only, October 2026)
- Polar Capital Healthcare Discovery Fund — Polar Capital · 2.6 % (largest positions only, October 2026)
- Nordea Global Social Empowerment — Nordea Funds · 0.95 % (full portfolio disclosed, September 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.24 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)
- MGI Global Equity Fund — Mercer · 0.01 % (full portfolio disclosed, December 2025)